Citation Impact
Citing Papers
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
2014 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Review of Epidemiological Evidence of Health Effects of Particulate Air Pollution
1995
Long-term air pollution exposure and cardio- respiratory mortality: a review
2013 Standout
A review of uses of health care utilization databases for epidemiologic research on therapeutics
2005 Standout
Association between mortality and indicators of traffic-related air pollution in the Netherlands: a cohort study
2002 Standout
An Introduction to the Fundamentals of Cohort and Case–Control Studies
2014
Alzheimer's disease
2011 Standout
Simeprevir and Sofosbuvir for Treatment of Chronic Hepatitis C Infection
2015
Epidemiology of COPD
2009 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Aircraft engine exhaust emissions and other airport-related contributions to ambient air pollution: A review
2014 Standout
Clearing the Air: A Review of the Effects of Particulate Matter Air Pollution on Human Health
2011 Standout
Antiviral treatment of hepatitis C
2014
Qualitative Research: Data Collection, Analysis, and Management
2015 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Benzodiazepines and hip fractures in elderly people: case-control study
2001
Metal–Organic Frameworks as Efficient Materials for Drug Delivery
2006 Standout
Particulate air pollution and hospital admissions in Christchurch, New Zealand
2002
Air pollution and health
2002 Standout
Cystic fibrosis
1998
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
2009
Incidence and Characteristics of Angioedema Associated With Enalapril
2005
Benzodiazepines with different half-life and falling in a hospitalized population
2000
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
Brief Report
2016
Actual Causes of Death in the United States, 2000
2004 Standout
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
Evaluating Medication Effects Outside of Clinical Trials: New-User Designs
2003 Standout
Woodsmoke Health Effects: A Review
2006 Standout
Plants and the central nervous system
2003 Standout
Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons
2009 Standout
Psychotropic Medications and the Risk of Fracture
2007
Modeling and comparison of dissolution profiles
2001 Standout
Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema*
1996
The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection
2017
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Psychological treatment for insomnia in the regulation of long-term hypnotic drug use
2004
Epidemiology of fine particulate air pollution and human health: biologic mechanisms and who's at risk?
2000
Health Effects of Fine Particulate Air Pollution: Lines that Connect
2006 Standout
Air Pollution and Cardiovascular Disease
2004 Standout
Epidemiology of Fine Particulate Air Pollution and Human Health: Biologic Mechanisms and Who's at Risk?
2000
Flexible Porous Metal-Organic Frameworks for a Controlled Drug Delivery
2008 Standout
Health and respirable particulate (PM10) air pollution: a causal or statistical association?
1996
On The Assessment of Similarity of Drug Dissolution Profiles—A Simulation Study
1997
Statistical Issues on the FDA Conjugated Estrogen Tablets Bioequivalence Guidance
1996
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
2015 Standout
Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection
2015
A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults
2016
Review of relationship between indoor and outdoor particles: I/O ratio, infiltration factor and penetration factor
2010 Standout
Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS 5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection
2014
Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B
2014 StandoutNobel
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Diagnostics for heteroscedasticity in regression
1983
Instrumental Variables and GMM: Estimation and Testing
2003 Standout
Short term variations in hospital admissions and mortality and particulate air pollution.
1997
Health effects of particulate air pollution: time for reassessment?
1995
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
2015 Standout
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Fast Hepatitis C Virus RNA Elimination and NS5A Redistribution by NS5A Inhibitors Studied by a Multiplex Assay Approach
2015 StandoutNobel
Statistical comparison between dissolution profiles of drug products
1997
Fine-Particulate Air Pollution and Life Expectancy in the United States
2009 Standout
A Comparison between Maximum Likelihood and Generalized Least Squares in a Heteroscedastic Linear Model
1982
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
Epidemiologic studies on short-term effects of low levels of major ambient air pollution components.
1995
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults
2017
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results
2017
Enhancement of food shelf life with polyvinyl alcohol-chitosan nanocomposite films from bioactive Eucalyptus leaf extracts
2020 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Statistical Evaluation of Similarity Factor f2 as a Criterion for Assessment of Similarity Between Dissolution Profiles
1997
Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential
2013
Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus
2016 StandoutNobel
Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort
2013
Identification of persons with cardiorespiratory conditions who are at risk of dying from the acute effects of ambient air particles.
2001
Works of Thomas Hammerstrom being referenced
High-Dose Pancreatic-Enzyme Supplements and Fibrosing Colonopathy in Children with Cystic Fibrosis
1997
Earlier Sustained Virologic Response End Points for Regulatory Approval and Dose Selection of Hepatitis C Therapies
2013
Sedative-hypnotic drugs and the risk of hip fracture
1996
Temporal patterns in air pollution and hospital admissions
1992
Asymptotically Optimal Tests for Heteroscedasticity in the General Linear Model
1981
A Meta-analysis to Assess the FDA DAVP’s TLOVR Algorithm in HIV Submissions
2011
Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whites
1996
Statistical Assessment of Mean Differences between Two Dissolution Data Sets
1996